Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
2
×
crispr
2
×
editas medicine
life sciences
national blog main
san francisco blog main
abbvie
allergan
alzheimer's disease
biotech
boston
cancer
clinical trials
crispr therapeutics
crispr-cas9
cynthia collins
deals
editas
gene editing
intellia therapeutics
leber congenital amaurosis type 10
michelle robertson
national
national top stories
p53
parkinson's disease
rare diseases
san francisco top stories
voyager therapeutics
What
editing
gene
genetic
2
×
abbvie
alliance
biotech
cancer
cas
cells
crispr
defect
drive
editas
edited
exits
experimental
fears
flag
guardian
human
known
lab
malfunction
medicine
medicines
nature
new
nicknamed
occurs
pact
papers
partnership
potential
pruning
published
raising
red
research
researchers
returning
Language
unset
Current search:
genetic
×
crispr
×
" boston top stories "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
